Journal
JOURNAL OF ENDOCRINOLOGY
Volume 259, Issue 1, Pages -Publisher
BIOSCIENTIFICA LTD
DOI: 10.1530/JOE-23-0082
Keywords
islet; pancreas; insulin secretion; autoimmune; diabetes
Categories
Ask authors/readers for more resources
This article provides an overview of the main themes discussed at the JDRF-DiabetesUK-INNODIA-nPOD symposium in Stockholm, Sweden, highlighting promising conclusions and key unmet needs in achieving better approaches to prevent or reverse T1D.
There is a growing understanding that the early phases of type 1 diabetes (T1D) are characterised by a deleterious dialogue between the pancreatic beta cells and the immune system. This, combined with the urgent need to better translate this growing knowledge into novel therapies, provided the background for the JDRF-DiabetesUK-INNODIA-nPOD symposium entitled 'Islet cells in human T1D: from recent advances to novel therapies', which took place in Stockholm, Sweden, in September 2022. We provide in this article an overview of the main themes addressed in the symposium, pointing to both promising conclusions and key unmet needs that remain to be addressed in order to achieve better approaches to prevent or reverse T1D.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available